Search

Tag: KarMMa-3 study

Pharma Industry News
Bristol Myers Squibb and 2seventy bio’s Abecma gets positive FDA committee vote for multiple myeloma

Bristol Myers Squibb and 2seventy bio’s Abecma gets positive FDA committee vote for multiple myeloma

businessnewstoday- March 18, 2024 0

In a significant development in the healthcare industry, Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) have announced a favorable vote by ... Read More